| 10851080 |
Methods of treatment using pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds |
Barbara J. Brandhuber, Timothy Kercher, Gabrielle R. Kolakowski, Shannon L. Winski |
2020-12-01 |
| 10835533 |
1 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor |
Steven W. Andrews, Brian Baer, Zackary Crane, Weidong Liu, Daniel J. Watson |
2020-11-17 |
| 10758542 |
Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors |
Steven W. Andrews, Kevin Ronald Condroski, Julia Haas, Lily Huang, Yutong Jiang +2 more |
2020-09-01 |
| 10730880 |
4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors |
Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer, John Gaudino +13 more |
2020-08-04 |